Captrust Financial Advisors Cocrystal Pharma, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.48 - $0.71 $960 - $1,420	2,000 Added 660.07%	2,303 $1,000
Q4 2021 Feb 14, 2022	BUY	$0.65 - $1.02 $24 - $37	37 Added 13.91%	303 $0
Q1 2021 May 17, 2021	SELL	$1.3 - $2.35 $5,200 - $9,400	-4,000 Reduced 93.76%	266 $0
Q2 2020 Aug 14, 2020	BUY	$0.7 - $1.58 $2,986 - $6,740	4,266 New	4,266 $6,000
Q4 2019 Feb 14, 2020	SELL	$0.39 - $2.05 $259 - $1,365	-666 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.06 - $2.75 $1,371 - $1,831	666 New	666 $2,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.